サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1686060

デジタルゲノムの世界市場レポート 2025

Digital Genome Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デジタルゲノムの世界市場レポート 2025
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デジタルゲノム市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR19.9％で971億3,000万米ドルに成長します。予測期間の成長は、遺伝性疾患の有病率の増加、デジタルゲノムに関する研究開発の増加、個別化医療の採用拡大、バイオテクノロジーの発展、慢性疾患の有病率の上昇に起因しています。予測期間における主な動向としては、次世代シーケンシング技術の採用増加、技術進歩の増加、診断産業における微生物の広範な利用、個別化医療に対する需要の増加、病院や診療所におけるデジタルゲノム技術の採用増加などが挙げられます。

遺伝性疾患の有病率の増加は、今後デジタルゲノム市場の成長を促進すると予想されます。遺伝性疾患は、個人のDNAの異常や変異によって引き起こされる遺伝性の疾患であり、身体の開発と機能の指示を伝える遺伝物質です。デジタルゲノム技術により、遺伝性疾患に関連する遺伝子変異や変異の同定が可能になります。この情報は、これらの疾患の正確かつ早期の診断に役立ち、タイムリーな介入と治療を可能にします。例えば、2023年8月、米国の医学図書館である国立医学図書館によると、鎌状赤血球貧血は米国のアフリカ系アメリカ人の約500人に1人が罹患する遺伝病です。さらに、アフリカ系アメリカ人の約12人に1人がこの病気の原因となる常染色体劣性突然変異を持ち、年間約30万人の乳児が鎌状赤血球貧血で生まれています。したがって、遺伝性疾患の有病率の増加がデジタルゲノム市場の成長を牽引しています。

デジタルゲノム市場で事業を展開する主要企業は、NovaSeq Xシリーズのような革新的な製品を開発し、疾病を理解し、最終的に患者の生活を変革することを目指しています。NovaSeq XシリーズにはNovaSeq XとNovaSeq X Plusシステムがあり、NovaSeq X Plusは1ランあたり128以上のゲノムをシーケンスし、年間2万以上の全ゲノムを生成することができます。例えば、2022年9月、米国のバイオテクノロジー企業であるイルミナ社は、全ゲノムシーケンス技術を大きく進化させたNovaSeq Xシリーズを発表しました。このシステムには、ワークフロー全体のコスト効率、合理化されたインフォマティクス、操作の簡素化、持続可能性の進歩、世界クラスのサポートが組み込まれています。また、より広範で深いシーケンシングを可能にし、より多くのサンプルを含むアプリケーションのスケールアップや、より効率的なデータ解析を可能にします。NovaSeq Xシリーズは、試薬の安定性が向上し、ゲノミクスデータ圧縮の最適化によりデータ転送が高速化された、最も強力でコスト効率の高いシーケンスシステムとして設計されています。このシステムは持続可能性の向上を目的に構築され、データフットプリントを小さくすることでストレージとエネルギー消費コストを削減します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界デジタルゲノムPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界のデジタルゲノム市場：成長率分析
  • 世界のデジタルゲノム市場の実績：規模と成長, 2019-2024
  • 世界のデジタルゲノム市場の予測：規模と成長, 2024-2029, 2034F
  • 世界デジタルゲノム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のデジタルゲノム市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • シーケンシングおよび分析機器
  • データ分析と管理ツール
  • 世界のデジタルゲノム市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断
  • 農業と動物調査
  • パーソナライズ医療
  • 創薬
  • 治療分析
  • 世界のデジタルゲノム市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 研究センターおよび政府機関
  • 学術機関
  • 製薬およびバイオテクノロジー産業
  • 病院
  • 診断センター
  • 世界のデジタルゲノム市場、シーケンシングおよび分析機器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 次世代シーケンシング（NGS）システム
  • サンガーシーケンシングシステム
  • シングルセルシーケンシング装置
  • 第3世代シーケンシング機器
  • 世界のデジタルゲノム市場、データ分析および管理ツールの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バイオインフォマティクスソフトウェア
  • データ管理プラットフォーム
  • クラウドベースの分析ソリューション
  • ワークフロー管理ツール

第7章 地域別・国別分析

  • 世界のデジタルゲノム市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のデジタルゲノム市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • デジタルゲノム市場：競合情勢
  • デジタルゲノム市場：企業プロファイル
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Agilent Technologies Inc.
  • Illumina Inc.
  • bioMerieux SA
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • BGI Genomics
  • Myriad Genetics Inc.
  • Foundation Medicine Inc.
  • ArcherDx Inc.
  • Invitae Corporation
  • Oxford Nanopore Technologies Ltd.
  • Luminex Corporation
  • GenMark Diagnostics Inc.
  • NanoString Technologies Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • デジタルゲノム市場2029：新たな機会を提供する国
  • デジタルゲノム市場2029：新たな機会を提供するセグメント
  • デジタルゲノム市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r27898

The digital genome refers to the digitized and organized collection of an organism's genetic material, including its DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) sequences. This digital representation allows for storing, analyzing, and interpreting genetic information using computational tools and technologies. Digital genomes are essential for understanding genetic variations, disease mechanisms, and evolutionary relationships.

The main types of digital genome are sequencing and analyzer instruments, and data analysis and management tools. Sequencing and analyzer instruments refer to equipment used in genomic sequencing and analysis processes, which are essential for decoding the genetic information contained within DNA and RNA molecules. They are used for various applications such as diagnostics, agriculture and animal research, personalized medicine, drug discovery, and treatment analysis by research centers and government institutes, academic institutions, pharmaceutical and biotechnology industries, hospitals, and diagnostic centers.

The main types of digital genome are sequencing and analyzer instruments, and data analysis and management tools. Sequencing and analyzer instruments refer to equipment used in genomic sequencing and analysis processes, which are essential for decoding the genetic information contained within DNA and RNA molecules. They are used for various applications such as diagnostics, agriculture and animal research, personalized medicine, drug discovery, and treatment analysis by research centers and government institutes, academic institutions, pharmaceutical and biotechnology industries, hospitals, and diagnostic centers.

The digital genome market size has grown rapidly in recent years. It will grow from $39.25 billion in 2024 to $46.94 billion in 2025 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to growing funding for genomics, reduced cost and high speed of DNA sequencing, entry of new players and start-ups in developing economies, increasing number of drug discoveries, and growing biotech sector.

The digital genome market size is expected to see rapid growth in the next few years. It will grow to $97.13 billion in 2029 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, increasing research and development pertaining to digital genome, growing adoption of personalized medicine, developments in biotechnology, and rising prevalence of chronic diseases. Major trends in the forecast period include the increasing adoption of next-generation sequencing technologies, increasing technological advancements, extensive use of microorganisms in diagnostics industry, increasing demand for personalized medicines, and rising adoption of digital genomic technology by hospitals and clinics.

The increasing prevalence of genetic disorders is expected to propel the growth of the digital genome market going forward. Genetic disorders are hereditary conditions caused by abnormalities or mutations in an individual's DNA, the genetic material that carries instructions for the development and functioning of the body. Digital genome technologies enable the identification of genetic mutations and variations associated with genetic disorders. This information helps in accurate and early diagnosis of these disorders, allowing for timely intervention and treatment. For instance, in August 2023, according to the National Library of Medicine, a US-based medical library, sickle cell anemia is a genetic disease that affects approximately 1 in 500 African Americans in the United States. Further, about 1 in 12 African Americans carries the autosomal recessive mutation responsible for the disease, and approximately 300,000 infants are born with sickle cell anemia annually. Therefore, the increasing prevalence of genetic disorders is driving the growth of the digital genome market.

Major companies operating in the digital genome market are developing innovative products such as the NovaSeq X Series to understand disease and ultimately transform patient lives. NovaSeq X Series includes the NovaSeq X and NovaSeq X Plus systems, with the NovaSeq X Plus capable of sequencing more than 128 genomes per run and generating more than 20,000 whole genomes per year. For instance, in September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series, a significant advancement in whole-genome sequencing technology. The system incorporates cost-efficiency throughout the workflow, streamlined informatics, operational simplicity, sustainability advancements, and world-class support. It also enables broader and deeper sequencing, allowing users to scale up any application to include more samples and analyze data more efficiently. The NovaSeq X Series is designed to be the most potent and cost-effective sequencing system, with improved reagent stability and faster data transfers due to optimized genomics data compression. The system was purpose-built for improved sustainability, with a smaller data footprint that reduces storage and energy consumption costs.

In January 2023, Agilent Technologies, a US-based company specializing in analytical solutions, acquired Avida Biomed for an undisclosed amount. This acquisition is aimed at strengthening Agilent Technologies' next-generation sequencing capabilities by incorporating Avida Biomed's target enrichment workflows. Avida Biomed is a US-based life sciences company that specializes in developing advanced target enrichment workflows for next-generation sequencing (NGS).

Major companies operating in the digital genome market are Roche Holding AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Quest Diagnostics, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., BGI Genomics, Myriad Genetics Inc., Foundation Medicine Inc., ArcherDx Inc., Invitae Corporation, Oxford Nanopore Technologies Ltd., Luminex Corporation, GenMark Diagnostics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Genewiz, Inscripta Inc., Genomic Health Inc., Becton Dickinson and Company, GenomeMe, Regeneron Pharmaceuticals Inc.

North America was the largest region in the digital genome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital genome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital genome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital genome market consists of revenues earned by entities by providing services such as DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) isolation, profiling, qPCR, next-generation sequencing, and advanced bioinformatics data analysis pipelines. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital genome market also includes sales of sequencing and analyzer instruments, sequencing chips, sample preparation instruments, and sequencing and analysis software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Genome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital genome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital genome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The digital genome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Sequencing And Analyzer Instruments; Data Analysis And Management Tools
  • 2) By Application: Diagnostics; Agriculture And Animal Research; Personalized Medicine; Drug Discovery; Treatment Analysis
  • 3) By End User: Research Centers And Government Institutes; Academic Institutions; Pharmaceutical And Biotechnology Industries; Hospitals; Diagnostic Centers
  • Subsegments:
  • 1) By Sequencing And Analyzer Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Single-Cell Sequencing Instruments; Third-Generation Sequencing Instruments
  • 2) By Data Analysis And Management Tools: Bioinformatics Software; Data Management Platforms; Cloud-Based Analysis Solutions; Workflow Management Tools
  • Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; GE HealthCare Technologies Inc.; Quest Diagnostics; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Genome Market Characteristics

3. Digital Genome Market Trends And Strategies

4. Digital Genome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Digital Genome Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Digital Genome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Digital Genome Market Growth Rate Analysis
  • 5.4. Global Digital Genome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Digital Genome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Digital Genome Total Addressable Market (TAM)

6. Digital Genome Market Segmentation

  • 6.1. Global Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing And Analyzer Instruments
  • Data Analysis And Management Tools
  • 6.2. Global Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Agriculture And Animal Research
  • Personalized Medicine
  • Drug Discovery
  • Treatment Analysis
  • 6.3. Global Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Centers And Government Institutes
  • Academic Institutions
  • Pharmaceutical And Biotechnology Industries
  • Hospitals
  • Diagnostic Centers
  • 6.4. Global Digital Genome Market, Sub-Segmentation Of Sequencing And Analyzer Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS) Systems
  • Sanger Sequencing Systems
  • Single-Cell Sequencing Instruments
  • Third-Generation Sequencing Instruments
  • 6.5. Global Digital Genome Market, Sub-Segmentation Of Data Analysis And Management Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioinformatics Software
  • Data Management Platforms
  • Cloud-Based Analysis Solutions
  • Workflow Management Tools

7. Digital Genome Market Regional And Country Analysis

  • 7.1. Global Digital Genome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Digital Genome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Genome Market

  • 8.1. Asia-Pacific Digital Genome Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Genome Market

  • 9.1. China Digital Genome Market Overview
  • 9.2. China Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Genome Market

  • 10.1. India Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Genome Market

  • 11.1. Japan Digital Genome Market Overview
  • 11.2. Japan Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Genome Market

  • 12.1. Australia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Genome Market

  • 13.1. Indonesia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Genome Market

  • 14.1. South Korea Digital Genome Market Overview
  • 14.2. South Korea Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Genome Market

  • 15.1. Western Europe Digital Genome Market Overview
  • 15.2. Western Europe Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Genome Market

  • 16.1. UK Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Genome Market

  • 17.1. Germany Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Genome Market

  • 18.1. France Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Genome Market

  • 19.1. Italy Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Genome Market

  • 20.1. Spain Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Genome Market

  • 21.1. Eastern Europe Digital Genome Market Overview
  • 21.2. Eastern Europe Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Genome Market

  • 22.1. Russia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Genome Market

  • 23.1. North America Digital Genome Market Overview
  • 23.2. North America Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Genome Market

  • 24.1. USA Digital Genome Market Overview
  • 24.2. USA Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Genome Market

  • 25.1. Canada Digital Genome Market Overview
  • 25.2. Canada Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Genome Market

  • 26.1. South America Digital Genome Market Overview
  • 26.2. South America Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Genome Market

  • 27.1. Brazil Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Genome Market

  • 28.1. Middle East Digital Genome Market Overview
  • 28.2. Middle East Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Genome Market

  • 29.1. Africa Digital Genome Market Overview
  • 29.2. Africa Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Genome Market Competitive Landscape And Company Profiles

  • 30.1. Digital Genome Market Competitive Landscape
  • 30.2. Digital Genome Market Company Profiles
    • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Digital Genome Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. bioMerieux SA
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Qiagen N.V.
  • 31.7. BGI Genomics
  • 31.8. Myriad Genetics Inc.
  • 31.9. Foundation Medicine Inc.
  • 31.10. ArcherDx Inc.
  • 31.11. Invitae Corporation
  • 31.12. Oxford Nanopore Technologies Ltd.
  • 31.13. Luminex Corporation
  • 31.14. GenMark Diagnostics Inc.
  • 31.15. NanoString Technologies Inc.

32. Global Digital Genome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Genome Market

34. Recent Developments In The Digital Genome Market

35. Digital Genome Market High Potential Countries, Segments and Strategies

  • 35.1 Digital Genome Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Digital Genome Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Digital Genome Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer